Literature DB >> 15957169

Genetic and environmental determinants of risk for cholangiocarcinoma via Opisthorchis viverrini in a densely infested area in Nakhon Phanom, northeast Thailand.

Satoshi Honjo1, Petcharin Srivatanakul, Hutcha Sriplung, Hiroko Kikukawa, Shuji Hanai, Kazuhiko Uchida, Takeshi Todoroki, Adisorn Jedpiyawongse, Pacharin Kittiwatanachot, Banchob Sripa, Somyos Deerasamee, Masanao Miwa.   

Abstract

Infection with Opisthorchis viverrini (OV) is associated with cholangiocarcinoma. OV is common in northeast Thailand, but less than 10% of the inhabitants develop cholangiocarcinoma. Animal experiments suggest that OV infection alone does not cause cholangiocarcinoma, and thus other environmental and genetic factors may play a role in causation. We conducted a population-based case-control study in which sex, age and place of residence were matched individually. Polymorphisms of GSTM1 and GSTT1 alone were not associated with risk for cholangiocarcinoma, while an elevated level of antibodies against OV (ELISA) > or = 0.200 was the strongest risk indicator (odds ratio as compared to that <0.200 = 27.09 [95% confidence interval (CI): 6.30-116.57]. Compared to subjects who had a normal antibody range and the wild-type GSTM1 gene, those who had elevated antibodies had higher odds ratios of 10.34 (95% CI: 1.31-81.63) [corrected] for wild-type GSTM1 and 18.00 (95% CI: 3.33-97.40) [corrected] for the null variant thereof, respectively. Past and current regular drinkers of alcohol had higher risk [odds ratio = 5.39 (95% CI: 1.11-26.06) and 4.82 (95% CI: 1.29-18.06), respectively]. Eating fermented products was an independent risk factor. Smokers or consumers of fermented fish had substantially increased risk if they were past or current drinkers. Infection with OV correlates strongly with cholangiocarcinoma, susceptibility to which may be possibly associated with GSTM1 polymorphism. Alcohol may affect metabolic pathways of endogenous and exogenous nitrosamines. Copyright 2005 Wiley-Liss, Inc

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15957169     DOI: 10.1002/ijc.21146

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  57 in total

1.  Combination of Praziquantel and Aspirin Minimizes Liver Pathology of Hamster Opisthorchis viverrini Infection Associated Cholangiocarcinoma.

Authors:  Pakkayanee Sudsarn; Thidarut Boonmars; Wipaporn Ruangjirachuporn; Nisana Namwat; Watcharin Loilome; Pranee Sriraj; Ratchadawan Aukkanimart; Wonkchalee Nadchanan; Songsri Jiraporn
Journal:  Pathol Oncol Res       Date:  2015-08-16       Impact factor: 3.201

2.  Immunohistochemical expression of mismatch repair genes: a screening tool for predicting mutator phenotype in liver fluke infection-associated intrahepatic cholangiocarcinoma.

Authors:  Upama Liengswangwong; Anant Karalak; Yukio Morishita; Masayuki Noguchi; Thiravud Khuhaprema; Petcharin Srivatanakul; Masanao Miwa
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

3.  Genetic variation in Opisthorchis viverrini (Trematoda: Opisthorchiidae) from northeast Thailand and Laos PDR based on random amplified polymorphic DNA analyses.

Authors:  Paiboon Sithithaworn; Chadaporn Nuchjungreed; Tuanchai Srisawangwong; Katsuhiko Ando; Trevor N Petney; Neil B Chilton; Ross H Andrews
Journal:  Parasitol Res       Date:  2006-10-03       Impact factor: 2.289

4.  A combination of liver fluke infection and traditional northeastern Thai foods associated with cholangiocarcinoma development.

Authors:  Pranee Sriraj; Thidarut Boonmars; Ratchadawan Aukkanimart; Jiraporn Songsri; Panupan Sripan; Panaratana Ratanasuwan; Sirintip Boonjaraspinyo; Nadchanan Wongchalee; Porntip Laummaunwai
Journal:  Parasitol Res       Date:  2016-06-07       Impact factor: 2.289

Review 5.  Infection with the carcinogenic human liver fluke, Opisthorchis viverrini.

Authors:  Michael J Smout; Banchob Sripa; Thewarach Laha; Jason Mulvenna; Robin B Gasser; Neil D Young; Jeffrey M Bethony; Paul J Brindley; Alex Loukas
Journal:  Mol Biosyst       Date:  2011-02-11

6.  Detection of salivary antibodies to crude antigens of Opisthorchis viverrini in opisthorchiasis and cholangiocarcinoma patients.

Authors:  Ponlatham Chaiyarit; Paiboon Sithithaworn; Chanitra Thuwajit; Puangrat Yongvanit
Journal:  Clin Oral Investig       Date:  2010-05-06       Impact factor: 3.573

Review 7.  Risk factors for cholangiocarcinoma.

Authors:  Gia L Tyson; Hashem B El-Serag
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425

Review 8.  Genetic and environmental determinants of risk for cholangiocarcinoma in Thailand.

Authors:  Masanao Miwa; Satoshi Honjo; Gyokukou You; Masakazu Tanaka; Kazuhiko Uchida; Petcharin Srivatanakul; Thiravud Khuhaprema; Watcharin Loilome; Anchalee Techasen; Chaisiri Wongkham; Temduang Limpaiboon; Puangrat Yongvanit; Sopit Wongkham
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

Review 9.  The treatment of cholangiocarcinoma: a hepatologist's perspective.

Authors:  Kamran Qureshi; Randhir Jesudoss; Abdullah M S Al-Osaimi
Journal:  Curr Gastroenterol Rep       Date:  2014-10

Review 10.  Cholangiocarcinoma.

Authors:  Nataliya Razumilava; Gregory J Gores
Journal:  Lancet       Date:  2014-02-26       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.